Cover Image

First‐in‐human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS‐penetrant soluble guanylyl cyclase stimulator

Abstract Soluble guanylate cyclase (sGC) and its product, cyclic guanosine monophosphate, play a role in learning and memory formation. Zagociguat (CY6463) is a novel stimulator of sGC being developed for the treatment of neurodegenerative disease. Single zagociguat doses of 0.3, 1, 3, 10, 20, 30, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebastiaan J. W. vanKraaij (Author), Pim Gal (Author), Laura G. J. M. Borghans (Author), Erica S. Klaassen (Author), Francis Dijkstra (Author), Christopher Winrow (Author), Chad Glasser (Author), Geert Jan Groeneveld (Author)
Format: Book
Published: Wiley, 2023-08-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items